| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |